They just got rid of the CFO and the head of IR. Those are visible positions. You have to wonder how many more they already took out.
That is what I see as the true news today. Yes, we knew that the Phase 2 study would be starting soon. What we didn't know was that they changed the design so that there are two studies and data could be announced after the first 12 week trial.
You have got to be joking. I guess you have never heard of Lipitor. Considered an also-ran before it came to market. if the first to market is always the winner why are there still pharma companies developing drugs? There are 100s of examples.
Two separate trials. First one is twelve weeks. Patients wanting to continue on will be enrolled in a second study which will continue treatment until 52 weeks (total).
He was born premature and has had some other issues but this is the one that has taken he worse toll on him recently. I am hoping by the time he is nearing adult size this will be on the market and available to him. Thanks for the prayers.
Wow, ok. I don't know you from Adam. You come on here talking fishing and I don't fish. They always put out a PR when they start a phase 2. I don't think it is a surprise. You do what you think best.
Better to get it right that to get it fast. By breaking it into two studies results from the first trial will come much quicker.
There are now two phase 2 trial. The 12 week and then the 52 week extension. Results will come quicker which is good news for shareholders.